Siwen Liu
Beijing Biocytogen (China)(CN)Jiangsu Cancer Hospital(CN)Second Affiliated Hospital of Jilin University(CN)Nanjing Medical University(CN)Northwest A&F University(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer-related molecular mechanisms research, Cancer-related cognitive impairment studies, RNA modifications and cancer, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner(2017)239 cited
- → LncRNA KTN1-AS1 promotes the progression of non-small cell lung cancer via sponging of miR-130a-5p and activation of PDPK1(2020)60 cited
- → LncRNA DHRS4-AS1 Inhibits the Stemness of NSCLC Cells by Sponging miR-224-3p and Upregulating TP53 and TET1(2020)44 cited
- → Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer(2018)40 cited
- → Theranostic nanoplatform to target macrophages enables the inhibition of atherosclerosis progression and fluorescence imaging of plaque in ApoE(−/−) mice(2021)32 cited
- → Long noncoding RNA and mRNA profiling in cetuximab‐resistant colorectal cancer cells by RNA sequencing analysis(2019)